Infectocef Saft (Cefaclor Monohydrate)

Cefaclor works by binding to penicillin‑binding proteins on bacterial cell walls, inhibiting the final steps of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and death of susceptible bacteria, thereby clearing the infection.

The dosage of Infectocef Saft is determined by the prescribing clinician based on the type and severity of infection, the patient’s age, weight, and renal function. The prescriber will provide specific instructions on how much suspension to take and how often.

Safety data for cefaclor in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the decision with their healthcare provider.

To order Infectocef Saft, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Cefaclor, as a second‑generation cephalosporin, offers broader coverage against certain Gram‑negative organisms compared with first‑generation agents like amoxicillin. It is generally more stable against beta‑lactamase enzymes, but may be less effective against some resistant strains where newer agents such as third‑generation cephalosporins or macrolides are preferred.

Infectocef Saft should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct light. The suspension should be shaken gently before each use to ensure uniform concentration, and any unused portion should be discarded after the labeled shelf‑life expires.

Infectocef Saft is taken orally as a liquid suspension. The prescribed dose should be measured with a calibrated dosing spoon or oral syringe provided with the product. It can be taken with or without food, unless the prescriber advises otherwise.

The most serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare skin disorders like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they develop symptoms such as difficulty breathing, severe rash, or persistent diarrhea.

Infectocef Saft should not be used by individuals with a known hypersensitivity to cefaclor, other cephalosporins, or penicillins. It is also contraindicated in neonates for certain infections and should be avoided in patients with a history of severe colitis unless specifically indicated by a physician.